Laura A. Williams, Chief Patient Officer at ARDELYX, INC. (ARDX), sold 81,898 shares at $5.99 ($490K) on 2026-06-18, disclosed to the SEC on 2026-06-22.
Scheduled sale ($490k) by Chief Patient Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARDX | SELL | 2026-02-23 | $48K | — | Filing → |
| ARDX | SELL | 2026-01-09 | $698K | — | Filing → |
| ARDX | SELL | 2025-11-25 | $36K | — | Filing → |